U.S. pharma huge copyright scrapped two experimental weight loss pills final year—a when-day-to-day capsule, lotiglipron, resulting from elevated liver enzymes and a twice-every day pill, danuglipron, because of potent Unwanted side effects—but CEO Albert Bourla has mentioned the company is set to “Engage in and get” within the obesity Area